AbbVie presented new results from the Phase III ECLIPSE trial (NCT06241313) at this year's Congress of the European Academy ...

Selecting a treatment plan to deal with acute migraine attacks can be like putting together a toolkit of possible therapies, individualized for each patient, one expert said. The toolkit should ...

Rimegepant (Vydura, Pfizer) has been recommended by the National Institute for Health and Care Excellence (NICE) as a cost-effective option for treating acute migraine in adults, forecasting that ...

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published in The BMJ. Triptans work by narrowing blood ...

Symbravo is not substitutable with other formulations of meloxicam or rizatriptan. The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of ...

An analysis of data from the Negev Migraine Cohort (2000-2023) found that people had 41% higher odds of seeking emergency ...

What is in a migraine cocktail? Discover the exact medications doctors use in the ER, plus how to safely use an at-home ...

The decision is supported by results from the Phase III ECLIPSE study, which assessed Aquipta versus placebo for migraine.

The American College of Physicians has provided a clinical guideline for migraine treatment, recommending the addition of triptan to NSAID or acetaminophen to treat moderate-to-severe acute episodic ...

Migraines require immediate attention, but not all popular hacks are equally effective. Dr Chawla shares tips that can help you make the right choice.

The drug lasmiditan, which is used to treat migraines, shows promise as a possible treatment for acute kidney injury, according to a new study from the University of Arizona. The findings are ...